Acadian Asset Management
NVNO

Acadian Asset Management’s enVVeno Medical NVNO Stock Holding History

Acadian Asset Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-195
Closed -$37K – 1865
2024
Q1 		$37K Buy
+195
New +$35K ﹤0.01% 1416

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Acadian Asset Management's NVNO Position: Q2 2024 in Review

Acadian Asset Management sold out of enVVeno Medical (NVNO) in Q2 2024, closing a stake of 195 shares — an estimated $37K sold.

Acadian Asset Management first reported a position in NVNO in Q1 2024 and held it in 1 quarter. The position peaked at $37K in Q1 2024. 26 funds tracked by Wall St. Rank hold NVNO as of Q2 2024.

  • Acadian Asset Management reported no remaining enVVeno Medical position as of Q2 2024 after selling out during the quarter.
  • Acadian Asset Management sold 195 enVVeno Medical shares in Q2 2024, an estimated $37K.
  • Acadian Asset Management first reported a position in enVVeno Medical in Q1 2024 and held it in 1 quarter.
  • Acadian Asset Management's enVVeno Medical position peaked at $37K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.